Author:
Bastion Y.,Reyes F.,Bosly A.,Gisselbrecht C.,Yver A.,Gilles E.,Maral J.,Coiffier B.
Reference5 articles.
1. Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin disease: possible synergy;Matthews;Lancet,1993
2. LNH-84: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma;Coiffier;J Clin Oncol,1989
3. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy;Coiffier;J Clin Oncol,1991
4. Lenograstim (glycosylated recombinant human G-CSF) supported chemotherapy optimisation in aggressive non-Hodgkin's lymphoma;Gissselbrecht;Proc Am Soc Clin Oncol,1993
5. A randomized double-blind phase III study of filgrastim (recombinant human G-CSF) versus placebo during intensive induction chemotherapy in 55 to 69-year old patients with poor prognosis aggressive non-Hodgkin's lymphoma;Bastion;Blood,1993
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献